On February 1, 2024, Friends of Cancer Research (FOCR) will hold a four-hour meeting in DC on "The Future of Diagnostic Tests." The lead speaker is Dr. Jeff Shuren, head of devices and diagnostics at FDA, on the FDA LDT regulatory proposal.
Scott Gottlieb, former head of FDA, will be the lunchtime keynote speaker. Registration is available both for the live meeeting and for the streaming audience.
https://friendsofcancerresearch.org/event/the-future-of-diagnostic-tests/
FDA-LDT is not the only topic. The meeting will also update with panels on digital pathology and HRD harmonization.
UPDATE: 48 hours ahead of the workshop, FOCR releases its 147 page, 2023 Scientific Report, "Regulatory Advancements for Patients." Here.
